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Summary 
Intraarterial infusion of vasoactive substances for ischemic conditions of the lower limbs 
in chronic occlusive arterial disease has been shown to be an effective therapeutic measure. 
Up to now there has been the dilemma of a limited therapy duration, because of the frequent 
and necessarily repeated single punction maneuvers. Percutaneously introduced longer lasting 
catheters do not present a reasonable alternative because of their comparatively short func-
tioning time. The implantation of a subcutaneously implaced port system with introduction of 
the infusion tube into a sid巴 branchof the femoral artery however provides an uncomplicated 
and permanent arterial access of low risk. The punctions of the catheter system are safe and 
can be done quickly and easily with minimal burden on the patients only. By using this 
device even longterm and/or repeated int巴rmittentarterial infusions for the treatment of 
chronic lower limb ischemia are made possible. 
Introduction 
There is no doubt that intraarterial administration of vasodilating substances has been 
established as an important remedy within the therapy of occlusive peripheral arterial disease. 
Especially in progressive stages there are certain well proven benefits of this kind of treatment. 
Since the introduction of Prostaglandi"n E1 by BERGSTROM in 19681' as a potent vasodilating 
agent and its intraarterial infusion into the femoral artery by CARLSON in 19735> there has 
been a great number of communications about the beneficial effects of this treatment3山 6,7,lll, 12, 
18・20> The reports claim th巴 healingof ischemic ulcers as well as a significant reduction of 
rest pain in Grade Il and N of FONTAINE’s classi日cation.
However in many cas巴Sthe severity of the disease requires a number of repeated therapies, 
which have to be performed over a longer period of time. The practical limitations of such 
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therapeutic measures have been the actual obstacles to prevent a broader and more intense 
use of intraarterial infusions. The necessity of numerous repeated arterial punctions causes 
a lot of undesired side effects, presenting the following main disadvantages: 
人） mechanical damage of the vascular wall by repeated punction maneuvers 
B) accompanying risk of arterial thrombosis or embolism 
C) increasing hematoma development in the punction area fol円引ingthe repeated removal of 
the iniection needles 
D) accompan：’ing danger of infection 
E) increasing pain of the p'.ltient after continuous cannulation of the femoral artery over a 
longer period. 
To avoid these disadvantages of repeated intraarterial infusions we developed a new sur-
gical approach to this kind of treatment, using a subcutaneously implanted port-a-cath system. 
The infusion catheter is implaced into a side branch of the femoral artery as has previously 
not been described、・et.
Method and Results 
For the exposure of the femoral artery we prefer a longitudinal incision in the inguinal 
region. The femoral artery is then exposed up to the inguinal ligament. As乳 nextstep a 
suitable side branch of the artery is looked for and prepared. The arteria circumflexa ilium 
superficialis which is found running along the inguinal ligament to the superior spina iliaca 
anterior seems to fit this purpose as well as the superficial epigastric artery, which runs in 
the subcutis to the ventral abdominal wall 19>. 
λfter having prepared such an appropriate vessel the silicone catheter c礼nbe introduced 
into the lumen. In some cases a slight dilatation of the artery may be necessary to bring 
the tube in. In our opinion one's attention then has to be focused on the fact that the tip of 
the catheter is strictly placed shortly before and in no case into the main lumen of the 
femoral artery (Picture :¥ o. 1). The system is then白liedwith saline solution and shortened 
to the proper length in accordance to the final port position. The port itself is日xedby some 
sutures to the abdominal wall. Its correct function and intravasal position is controlled by 
punctioning the system with a saline-heparin filled syringe (as shown in Picture No. 2). We 
only use so called Huberneedles for punction purpose to assure a long life of the port-
membrane酌 Thepunction reservoir should not be placed into the belt line to prevent later 
mechanical irritations of the patient. 
Up to now ¥ e have treated 4 patients with progressive stages of peripheral arterial 
occlusive disease through intermittent arterial Prostaglandin E1 infusions via port systems with 
sufficient and encouraging clinical results. Rest pain could be significantly lowered except in 
one case. Two patients had been treated bv hemodialysis for more than ten years showing 
severe diabetic disease in addition to訂 teri辻locclusion. In one of these two cases several toe 
amputations had been carried out over a period of two years without curing the defects. 
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Fig. l. The port system is subcutaneously placed and fixed on to the abdominal wall with 
appropriate sutures. The tip of the catheter is positioned directly before the main 
lumen of the femoral artery after its introduction through a side branch like the 
arte円・acircumflexa ilium sz抑 rficz"alz"sor an other suitable side vessel and then 
stitched to the vasal wall to prevent dislocation. 
After a three month period of intraarterial PG E1 infusions the ulcer of the forefood could be 
healed and the patient has been without relapse for one year now. In no case further ampu-
tations after the continuous treatment had been necessary up to now (Table 1). 
Discussion 
The efficacy of intraarterially administered Prostaglandin E1 as well as other vasodilating 
substances in stage I and N of peripheral arterial vascular disease has been shown for many 
times in the literatur巴丸山i4,rn,although the exact mechansims of action are not completely 
understood 2，山 Similarto Prostacyclin the Prostaglandin E1 acts through a platelet-aggregation 
inhibiting effect besides the vasodilatation. This is mediated by direct relaxation of smooth 
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Fig. 2. The port is punctured with a Huber-needle to control the correct intravasal position 
of the catheter system and to rinse the system with heparine-saline solution after 
五nishingthe intraarterial perfusion. 
Table I. Clinical features of 4 patients with continuous intermittent intraarterial 
lower limb perfusion with Prostaglandin E1 
Case Athero- Earlier Immediate efects Side age[Years] sclerosis Diabetes amputations Gangrene of intraart・pge1 efects 
1 33 ＋け ＋ 廿十 ＋ Disappearance of 。
pain, healing of 
ulcer 
2 58 制叶 ＋ 什 ＋十 Ulcer healing, 。
died 3 months 
later, renal failure, 
+after dialysis 
3 77 ＋十 Disappearance 。
of pain 
4 81 判十 十 No change 。
vascular muscles on the one hand 16) and stimulation of platelet-adenylat-cyclase on the other 
hand20) The risk of undesired systemic side effects and complications is decreased because 
passing the lung capillary bed the substance is almost totally destroyed and inactivated20) 
These observations are confirmed by the clinical reports of a reduction of rest pain and 
lowered consumption of analgetics as well as the healing of ulcers. Further on an improvement 
of the Grade of Fontaine’s classification, a fal of the rate of amputations or the possible 
preservation of a functioning limb and a shifitng of the amputation line further to the distal 
end if amputation is unavoidable are also ascribed to this kind of treatment18) However such 
therapies have to be repeated over a longer period of weeks and months, especially in the 
elderly patient. This almost inevitably implies the numerous disadvantages of the countless 
single arterial punctions. The main handicaps of this procedure are the additional unavoidable 
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mechanical vascular wall damage with eventually resulting arterial thrombosis or embolism, 
the increasing hematoma production after removal of the punction cannula, the risk of in-
fection and the personal discomfort and pain of punction area felt by the patients. 
The search for alternatives leads to the application of transcutaneously introduced intra-
arterial catheters. This procedure provides only a comparatively short duration of possible 
treatment as it is not suitable for continual therapy over weeks or months due to the almost 
inevitable risk of infection or thrombosis. This calamity brought us to the invention of 
subcutaneously implanted port systems as a permanent arterial access. In central venous 
locations such systems have shown to be effective and elegant solutions for repeated adminis-
tration of chemotherapeutics or for prolonged parenteral nutrition8•9l. The indirect 'arterial’ 
punction can be done easily, quickly and safely. As an additional effect the cannulation 
itself is nearly painless for the patients. Compliance of repeated intraarteial drug application 
is significantly higher than in case of single punction maneuvers. The treatment can be 
performed in outpatients and does not des巴rvea longer stay in the hospital. The total hospital 
stay in chronic arterial occlusive disease patients may prospectively be shortened. Infections 
of the punction area are seldom when careful desinfection of this region precedes the 
cannulation肋 Afterhaving completed the respective perfusion with an infusion pump we 
suggest rinsinεthe system with a heparin-saline solution before removing the needle.～1Ve believe 
that this will prevent a thrombosis of the catheter. In our experience it seems to be possible 
to perform continual arterial therapy over a period of several months and in some individual 
cases over years. 
The subcutaneous port system also provides the possibility of intraart巴rialinfusions of 
drugs other than the Prostaglandin E1 described here, such as thrombolytic substances, heparin, 
antibiotics or other hemorrheological substances. This would imply a correspondingly wider 
spectrum of indications for this kind of therapy. 
The direct implantation of the catheter into the main femoral artery lumenlll can not be 
recommended because of the disadvantageouslv altered blood flow conditions under these 
circumstances. An arterial thrombosis or embolism could possibly arise from such a technique 
as a result of the altered hemodynamics. On 1he other hand the implacement of the catheter 
tip into a side branch immediately before the main femoral artery lumen does not alter the 
quality of femoral arterial blood flow as is suggested by our modi五cationof arterial access. 
Although we did not install a non-return-valve into the distal tube part we did not see an 
証dverseeffect on catheter function up to now. 
Conclusion 
The new surgical approach of implanting a subcutaneously implaced port system into a 
side branch of th巴femoralartery for repeated intraarterial application of vasodilating or other 
pharmacological substances provides an easy and reliable type of permanent arterial access. 
Arterial punction can be performed quickly, safely and simp!I・ over a long period without a 
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considerable burden on the patient. Thus the technique lends itself as a method of choice to 
continuous repeated long term intraarterial administration of vasoactive or other drugs within 
the spectrum of therapeutic mod乱litiesof chronic peripheral arterial occlusive disease. 
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